Vitamin K2 in electron transport system: Are enzymes involved in vitamin K2 biosynthesis promising drug targets?

Molecules

Volumn 15, Issue 3, 2010, Pages 1531-1553

  Kurosu, Michio ^a   Begari, Eeshwaraiah ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Antibacterial agent; Electron transport system; Electron transport system inhibitor; MenA; Menaquinone; Menaquinone biosynthesis; Menaquinone biosynthesis inhibitor; Multidrug resistant bacteria; Vitamin K2

Indexed keywords

FARNOQUINONE;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; ELECTRON TRANSPORT; HUMAN; METABOLISM; REVIEW;

DRUG DISCOVERY; ELECTRON TRANSPORT; HUMANS; MOLECULAR STRUCTURE; VITAMIN K 2;

EID: 77950354085     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15031531     Document Type: Review

References (112)

1. Usui, Y.; Tanimura, H.; Nishimura, N.; Kobayashi, N. Vitamin K concentrations in the plasma and liver of surgical patients. Am. J. Clin. Nutr. 1990, 51, 846-852.
2. Kindberg, C. G.; Suttie, J. W. J. W. Effect of various intakes of phylloquinone on signs of vitamin K deficiency and serum and liver phylloquinone concentrations in the rat. Vitamins 1989, 175-180.
3. Collins, M. D.; Jones, D. Distribution of isoprenoid quinone structual types in bacterial and their taxonomic implications. Microbiol. Rev. 1981, 45, 316-354.
4. Nomenclature of quinones with isoprenoid side-chains. Pure Appl. Chem. 1974, 38, 439-447.
5. Suttie, J. W. Synthesis of vitamin K dependent proteins. FASEB 1993, 7, 445-452.
6. Cain, D.; Hutson, S. M.; Wallin, R. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase. J. Biol. Chem. 1997, 272, 29068-29075.
7. Jin, D.-Y.; Tie J.-K.; Stafford, D. W. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K. Biochemistry 2007, 46, 7279-7283.
8. Vogel, H. J.; Brokx, R. D.; Ouyang, H. Calcium-binding proteins. Method. Mol. Biol. 2002, 172, 1940-6029.
9. Francis, C. W. Warfarin: An historical perspective. Hematology 2008, 251.
10. Gebauer, M. Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg. Med. Chem. 2007, 15, 2414-2420. (Pubitemid 46240909)
11. Kuruvilla, M.; Gurk-Turner, C. A review of warfarin dosing and monitoring. BUMC Proc. 2001, 14, 305-306.
12. Vermeer, C.; Gijsbers, B. L.; Craciun, A. M.; Groenen-van Dooren, M. M. C. L.; Knapen, M. H. Effects of vitamin K on bone mass and bone metabolism. Am. Inst. Nutr. 1996, 1187S-1191S. (Pubitemid 26105656)
13. Iwamoto, J.; Yeh, J. K.; Takeda, T.; Ichimura, S.; Sato, Y. Comparative effects of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone 2003, 33, 557-566. (Pubitemid 37222382)
14. Visser, C. M. Some speculations on the mechanisms of the vitamins E and K starting from origin of life considerations and the antioxidant theory. Bioorg. Chem. 1980, 9, 411-422.
15. Shirakawa, H.; Ohsaki, Y.; Minegishi, Y.; Takumi, N.; Ohinata, K.; Furukawa, Y.; Mizutani, T.; Komai, M. Vitamin K deficiency reduces testosterone production in the testis through downregulation of the Cyp11a a cholesterol side chain cleavage enzyme in rats. Biochim. Biophys. Acta 2006, 1760, 1482-1488. (Pubitemid 44428023)
16. Awato, K. Prostate and menadiol sodium diphosphate. 1. Menadiol sodium diphosphate as a new substrate for measuring acid phosphatase activity and a discussion of prostatic tumor models. Nippon Hinyokika Gakkai Zasshi 1982, 73, 507-515.
17. Munter, G.; Hershko, C. Increased warfarin sensitivity as an early manifestation of occult prostate cancer with chronic disseminated intravascular coagulation. Act. Haematol. 2001, 105, 97-99. (Pubitemid 32620109)
18. 2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-and fluorouracil in vitro. Hepatol. Res. 2006, 35, 289-295. (Pubitemid 44138491)
19. Thijssen, H. H. W.; Drittij-Reijnders, M. J. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. British J. Nutr. 1996, 75, 121-127.
20. Yoshitomo, S.; Shinya, A.; Aya, M.; Yuka, S.; Kimie, N.; Maya, K.; Naoko, T.; Toshio, O. Synthesis and development of biologically active fluorescent-labeled vitamin K analogues and monitoring of their subcellular distribution. Tetrahedron 2008, 64, 8789-8796.
21. 1 to MK-4. Clin. Calcium 2009, 19, 1779-1787.
22. Usui, Y.; Tanimura, H.; Nishimura, N.; Kobayashi, N.; Okanoue, T.; Ozawa, K. Vitamin K concentrations in the plasma and liver of surgical patients. Am. J. Clin. Nutr. 1990, 5, 846-852.
23. Mitchell, P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961, 191, 144-148.
24. Mitchell, P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev. Cambridge Phil Soc. 1966, 41, 445-502.
25. Mitchell, P. Chemiosmotic coupling in energy transduction: A logical development of biochemical knowledge. Bioenergetics 1972, 3, 5-24.
26. Mellors A.; Tappel, A. L. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J. Biol. Chem. 1966, 241, 4353-4356.
27. 10. Ann. NY. Acad. Sci. 2002, 959, 396-411. (Pubitemid 34457579)
28. Harman, D. Free radicals in aging. Mol. Cell. Biochem. 1988, 84, 55-61.
29. Emster, L.; Dallner, G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271, 195-204.
30. Folkers, K.; Langsjoen, P. H.; Willis, R.; Richardson, P.; Xia, L.; Ye, C.; Tamagawa, H. (1990) Lovastatin decreases coenzyme Q levels in humans. Proc. Natl. Acad Sci. 1990, 87, 8931-8934.
31. Szkopishka, A. Ubiquinone. Biosynthesis of quinone ring and its isoprenoid side chain. Intracellular localization. Acta Biochim. Pol. 2000, 47, 469-480.
32. Haddock, B. A.; Colin, J. W. Bacterial respiration. Bacteriol. Rev. 1977, 41, 47-99.
33. Yasuhiro, A. Bacterial electron transport chains. Ann. Rev. Biochem. 1988, 57, 101-312.
34. Suvana, K. D.; Stevenson, R.; Meganathan, R.; Hudspeth, M. E. S.; Menaquinone (vitamin K2) biosynthesis: localization and characterization of the menA gene from Escherichia coli. J. Bacteriol. 1998, 180, 2782-2787. (Pubitemid 28213284)
35. 2 biosynthesis. J. Biol. Chem. 2003, 24, 42352-4236.
36. Bishop, D. H. L.; Pandya, K. P.; King, H. K. Ubiquinone and vitamin K in bacteria. Biochem. J. 1962, 83, 606-614.
37. Das, A.; Hugenholtz, J.; van Halbeek, H.; Ljungdal, L. G. Structure and function of a menaquinone involved in electron transport in membranes of Clostridium thermoautotrophicum and Clostridium thermoaceticum. J. Bacteriol. 1989, 171, 5823-5829.
38. Martin, J. L.; M. McMillan, F. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. Curr. Opin. Struct. Biol. 2002, 12, 783-793.
39. Bentley, R.; Meganathan, R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol. Rev. 1982, 46, 241-280.
40. Bentley, R. Biosynthesis of vitamin K and other natural naphthoquinones. Pure Appl. Chem. 1975, 41, 47-68.
41. Shineberg, B.; Young, I. G. Biosynthesis of bacterial menaquinones: the membrane-associated 1,4-dihydroxy-2-naphthoate octaprenyltransferase of Escherichia coli. Biochemistry 1976, 15, 2754-2758.
42. Meganathan, R.; Bentley, R. Biosynthesis of o-succinylbenzoic acid in a men-Escherichia coli mutant requires decarboxylation of L-glutamate at the C-1 position. Biochemistry 1981, 20, 5336-5340.
43. 1. Proc. Natl. Acad. Sci. USA 2009, 106, 5599-5603.
44. Schoepp-Cotheneta, B.; Lieutauda, C.; Baymanna, F.; Vermégliob, A.; Friedrichc, T.; Kramer, D. M.; Nitschke, W. Menaquinone as pool quinone in a purple bacterium. Proc. Natl. Acad. Sci. USA 2009, 106, 8549-8554.
45. Hiratsuka, T.; Furihata, K.; Ishikawa, J.; Yamashita, H.; Itoh, N.; Seto, H.; Dair, T. An Alternative menaquinone biosynthetic pathway operating in microorganisms. Science 2008, 321, 1670-1673.
46. Shaw, D. J.; Rice, D. W.; Guest, J. R. Homology between CAP and Fnr, a regulator of anaerobic respiration in Escherichia coli. J. Mol. Biol. 1983, 166, 241-247.
47. Unden G. Differential roles for menaquinone and demethylmenaquinone in anaerobic electron transport of E. coli and their fnr-independent expression. Arch. Microbiol. 1988, 150, 499-503.
48. Kaiser, M.; Sawers, G. Overlapping promoters modulate Fnr-and ArcA-dependent anaerobic transcriptional activation of the focApfl operon in Escherichia coli. Microbiology 1997, 143, 775-783.
49. Zigha, A.; Rosenfeld, E.; Schmitt, P.; Duport, C. The redox regulator Fnr is required for fermentative growth and enterotoxin synthesis in bacillus cereus F4430/73. J. Bacteriol. 2007, 189, 2813-2824 and references therein.
50. Hollfinder, R. The dependence on quinone specificity of terminal electron transport of bacteria. Curr. Microbiol. 1981, 6, 155-159.
51. Carlone, G. M.; Schalla, W. O.; Moss, C. W.; Ashlley, D. L.; Fast, D. M.; Holler, J. S.; Plikaytis, B. D. Haemophilus ducreyi isoprenoid quinone content and structure determination. Int. J. Syst. Bacteriol. 1988, 38, 249-253.
52. Kröger, A.; Unden, G. The function of menaquinone in bacterial electron transport. In Coenzyme Q; Lenz, G., Ed.; John Wiley & Sons: New York, NY, USA, 1985; pp. 285-300.
53. Vaidya, A. B.; Paintera, H. J.; Morriseya, J. M.; Mathera, M. W. The validity of mitochondrial dehydrogenases as antimalarial drug targets. Trends Parasitol. 2007, 24, 8-9.
54. Painter, H. J.; Morrisey, J. M.; Mather, M. W.; Vaidya, A. B. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 2007, 446, 88-91.
55. Smilkstein, M. J.; Forquer, I.; Kanazawa, A.; Kelly, J. X.; Rolf, W.; Winter, R. W.; Hinrichs, D. J.; Kramer, D. M.; Riscoe, M. K. Mol. Biochem. Parasitol. 2008, 159, 64-68.
56. 1 complex. J. Biol. Chem. 2003, 278, 31312-31318.
57. Weistein, E. A.; Yano, T.; Li, L.-S.; Avarbock, D.; Avarbock, A.; Helm, D.; McColm, A. A.; Duncan, K.; Lonsdale, J. T.; Rubin, H. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc. Natl. Acad. Sci. USA 2005, 102, 4548-4553.
58. Shi, L.; Sohaskey, C. D.; Kana, B. D.; Dawes, S.; North, R. J.; Mizrahi, V.; Gennaro, M. L. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc. Natl. Acad. Sci. USA 2005, 102, 15629-15634.
59. Yano, T.; Li, L. S.; Weinstein, E.; Teh, J. S.; Rubin, H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis Type-II NADH-menaquinone oxidoreductase (NDH-2). J. Biol. Chem. 2006, 281, 11456-11463.
60. Dekeyser, M. Acaricide mode of action. Pest Manag. Sci. 2005, 61, 103-110.
61. Estornell, E. Mitochondrial complex I: new insights from inhibitor assays. Plotoplasma 2000, 213, 11-17.
62. Sharova, I. V.; Vekshin, N. L. Rotenone-insensitive NADH oxidation in mitochondrial suspension is performed by NADH dehydrogenase of respiratory chain fragments. Biofizika 2004, 49, 814-821.
63. Bai, Y. L. Acaricides with different modes of action. Xiandai Nongyao 2005, 4, 27-30.
64. Wood, E.; Latli, B.; Casida, J. E. Fenazaquin acaricide specific binding sites in NADH:ubiquinone oxidoreductase and apparently the ATP synthase stalk. Pestic. Biochem. Physiol. 1996, 54, 135-145.
65. Hochstein, L. I.; Cronin, S. E. Electron transport in Paracoccus halodenitrificans and the role of ubiquinone. NASA Tech. Memo. 1983, 23, 572-577.
66. Lindell, S. D.; Ort, O.; Lümmen, P.; Klein, R. The design and synthesis of novel inhibitors of NADH:ubiquinone oxidoreductase. Bioorg. Med. Chem. Lett. 2004, 14, 511-514.
67. Beautement, K.; Clough, J. M.; de Fraine, P. J.; Godfrey, C. R. A. Fungicidal betamethoxyacrylates: from natural products to novel synthetic agricultural fungicides. Pestic Sci. 1991, 31, 499-519.
68. Bermejo, A.; Figadere, B.; Zafra-Polo, M.-C.; Barrachina, I.; Estornell, E.; Cortes, D. Acetogenins from Annonaceae: Recent progress in isolation, synthesis and mechanisms of action Nat. Prod. Rep. 2005, 22, 269-303.
69. Son, J. K.; Kim, D. H.; Woo, M. H. Two new epimeric pairs of acetogenins bearing a carbonyl group from Annona cherimolia seeds. J. Nat. Prod. 2003, 66, 1369-1372.
70. 1 complex: Function in the context of structure. Annu. Rev. Physiol. 2004, 66, 689-733.
71. 1 complex from bovine heart mitochondria. Science 1997, 277, 60-66.
72. Smith, J. L.; Zhang, H.; Yan, J.; Kurisu, G.; Cramer, W. A. Cytochrome bc complexes: a common core of structure and function surrounded by diversity in the outlying provinces. Curr. Opini. Struct. Biol. 2004, 14, 432-439.
73. 1 complex. Science 1998, 281, 64-71.
74. 1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Structure (Lond). 2000, 8, 669-684.
75. 1. Nature 1998, 392, 677-684.
76. 1 complex with its bound substrate cytochrome c. Proc. Natl. Acad. Sci. USA 2002, 99, 2800-2805.
77. 1 complex from the anoxigenic, photosynthetic bacterium Rhodobacter sphaeroides. J. Bioenerg Biomembr. 2008, 40, 485-92.
78. Tappel, A. L. Inhibition of electron transport by antimycin A, alkyl hydroxy naphthoquinones and metal coordination compounds. Biochem. Pharmacol. 1960, 3, 289-296.
79. 1 complex: A new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. J. Mol. Biol. 2005, 351, 573-597.
80. Kotova, E. A.; Oleskin, A. V.; Samuilov, V. D. Effect of myxothiazol on the electrogenic redox chain of purple photosynthetic bacteria. Photobiochem. Photobiophys. 1983, 6, 211-221.
81. Crowley, P. J.; Aspinall, I. H.; Gillen, K.; Godfrey, C. R. A.; Devillers, I. M.; Munns, G. R.; Sageot, O.-A; Swanborough, J.; Worthington, P. A.; Williams, J. The crocacins: Novel natural products as leads for agricultural fungicides. Chimia 2003, 57, 685-691.
82. 1 complex. J. Biol. Chem. 2008, 283, 28087-28094.
83. van Nieuwenhuyse, P.; van Leeuwen, T.; Khajehali, J.; Vanholme, B.; Tirry, L. Mutations in the mitochondrial cytochrome b of Tetranychus urticae Koch (Acari: Tetranychidae) confer crossresistance between bifenazate and acequinocyl. Pest. Manag. Sci. 2009, 65, 404-412.
84. Koura, Y.; Kinoshita, S.; Takasuka, K.; Koura, S.; Osaki, N.; Matsumoto, S.; Miyoshi, H. Respiratory inhibition of acaricide AKD-2023 and its deacetyl metabolite. Nihon Noyaku Gakkaishi (J. Pestic. Sci.) 1998, 23, 18-21.
85. Caboni, P.; Sarais, G.; Melis, M.; Cabras, M.; Cabras, P. Determination of acequinocyl and hydroxyacequinocyl on fruits and vegetables by HPLC-DAD. J. Agric. Food Chem. 2004, 52, 6700-6702.
86. Takatsuki, A; Tamura, G; Arima, K. Antiviral and antitumor antibiotics. XIV. Effects of ascochlorin and other respiration inhibitors on multiplication of Newcastle disease virus in cultured cells. Appl. Microbiol. 1969, 17, 825-829.
87. 1 complex. Biochem. Biophy. Acta 2010, 1797, 360-370.
88. Song, C.; Scharf, M. E. Mitochondrial impacts of insecticidal formate esters in insecticideresistant and insecticide-susceptible Drosophila melanogaster. Pest. Manag. Sci. 2009, 65, 697-703.
89. Hong, S.; Park, K. K.; Magae, J.; Ando, K.; Lee, T. S.; Kwon, T. K.; Kwak, J. Y. Kim, C. H.; Chang, Y. C. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway. J. Bio. Chem. 2005, 280, 25202-25209.
90. Marques, M. A.; Citronb, D. M.; Wang, C. C. Development of tyrocidine A analogues with improved antibacterial activity. Bioorg. Med. Chem. 2007, 15, 6667-6677.
91. Romagnoli, S.; Oettmeier, W.; Zannoni, D. The effects of decyl aurachins C and D on the respiratory electron flow of facultative phototrophic bacteria. Biochem. Mol. Biol. Int. 1996, 39, 671-678.
92. Kitagawa, W.; Tamura, T. A quinolin antibiotic from Phodococcus erthropolis JCM 6824. J. Antibiot. 2008, 61, 680-682.
93. Kitagawa, W.; Tamura, T. Three types of antibiotics produced from Phodococcus erthropolis strains. Microbes Environ. 2008, 23, 167-171.
94. Gonzalez, M.; Carmen, S.; Miguel, A.; Rao, K.; Sundar, Z.-P.; Marmen, M.; Cortes, D. Prenylated benzopyran derivatives from two Polyalthia species. Phytochemistry 1996, 43, 1361-1364.
95. Zafra-Polo, M. C.; González, M. C.; Tormo, J. R.; Estornell, E.; Cortes, D. Polyalthidin: New prenylated benzopyran inhibitor of the mammalian mitochondrial respiratory chain. J. Nat. Prod. Chem. 1996, 59, 913-916. (Pubitemid 26365480)
96. López-Gresa, M. P.; Cabedo, N.; González-Mas, M. C.; Ciavatta, M. L.; Avila, C.; Primo, J. Terretonins E and F, inhibitors of the mitochondrial respiratory chain from the marine-derived fungus Aspergillus insuetus. J. Nat. Prod. 2009, 72, 1348-1351.
97. Kurosu, M.; Narayanasamy, P.; Biswas, K.; Dhiman, R.; Crick, D. C. Discovery of 1,4-dihydroxy-2-naphthoate prenyltransferase inhibitors: New drug leads for multidrug-resistant Gram-positive pathogens. J. Med. Chem. 2007, 50, 3973-3975. (Pubitemid 47301729)
98. Wayne, L. G.; Hayes, L. G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 1996, 64, 2062-2069.
99. Wayne, L. G.; Sramek, H. A. Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis. Infect. Immun. 1979, 24, 363-370.
100. Wayne, L. G.; Sramek, H. A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1994, 13, 908-912.
101. Kurosu, M.; Crick, D. C. MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis. Med. Chem. 2009, 5, 197-207.
102. Dhiman, R. K.; Mahapatra, S.; Slayden, R. A.; Boyne, M. E.; Lenaerts, A.; Hinshaw, J. C.; Angala, S. K.; Chatterjee, D.; Biswas, K.; Narayanasamy, P.; Kurosu, M.; Crick, D. C. Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol. Microbiol. 2009, 72, 85-97.
103. Lu, X.; Zhang, H.; Tonge, P. J.; Tan, D. S. Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis. Bioorg. Med. Chem. Lett. 2008, 18, 5963-5966.
104. Zhang, H.; Tonge, P. J. Enzymatic activity in the crotonase superfamily: The mechanism of the reactions catalyzed by 1,4-dihydroxynaphthoyl-CoA synthase (MenB) and 2-ketocyclohexanecarboxyl-CoA hydrolase (BadI). In 234th ACS National Meeting, Boston, MA, USA, 19-23 August 2007.
105. Li, X.; Zhang, H.; Tonge, P. J. Inhibition of 1,4-dihydroxynaphthoyl-CoA synthase (MenB), an enzyme drug target bacterial menaquinone biosynthesis pathway. In 236th ACS National Meeting, Philadelphia, PA, USA, 17-21 August 2008.
106. Xu, H.; Graham, M.; Karelis, J.; Walker, S. G.; Peter J. Tonge, P. J. Mechanistic studies of MenD, 2-succinyl-5-enoylpyruvyl-6-hydroxy-3-cyclohexene- 1-carboxylic acid synthase from Staphylococcus aureus. In 237th ACS National Meeting, Salt Lake City, UT, USA, 22-26 March 2009.
107. Hossein, D. G. Stereobiochemical aspects of warfarin isomers for inhibition of enzymatic alkylation of menaquinone-0 to menaquinone-4 in chick liver. Int. J. Vitam. Nutr. Res. 1978, 48, 131-135.
108. Koul, A.; Vranckx, L.; Dendouga, N.; Balemans, W.; van den Wyngaert, I.; Vergauwen, K.; Göhlmann, H. W. H.; Willebrords, R.; Poncelet, A.; Guillemont, J.; Bald, D.; Andries, K. Diarylquinolines are bactericidal for dormant Mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem. 2008, 283, 25273-25280.
109. Cole, S. T.; Alzari, P. M. TB-a new target, a new drug. Science 2005, 307, 214-215.
110. Honaker, R. W.; Leistikow, R. L.; Bartek, I. L.; Voskuil, M. I. Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy. Infect. Immun. 2009, 77, 3258-3263.
111. Farrand, S. K.; Taber, H. W. Physiological effects of menaquinone deficiency in Bacillus subtilis. J. Bacteriol. 1973, 115, 1035-1044.
112. Lemma, E.; Unden, G.; Kröger, A. Menaquinone is an obligatory component of the chain catalyzing succinate respiration in Bacillus subtilis. Arch. Microbiol. 1990, 155, 62-67.